Exploring the Future of Biotech Investment: The Therapeutics Panel at RESI Europe 

25 Feb

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

With biotech venture capital investment surging by over 33% in 2024 and in-licensing activity remaining strong, optimism is growing in the life science ecosystem. The Therapeutics panel at RESI Europe in Barcelona, taking place at the InterContinental Hotel on April 1, will bring together key investors to explore the evolving landscape of biotech investment and partnerships.

This panel will examine emerging trends and therapeutic breakthroughs, providing insight into the indications and modalities attracting investor interest. Discussions will also highlight the role of venture capital and in-licensing partners in driving innovation, as well as key considerations for biotech companies navigating R&D and scaling operations. Given the high-risk nature of early-stage biotech investment, panelists will share perspectives on how to de-risk opportunities through due diligence and strategic partnerships.

Moderated by Jim McGough of Mid Atlantic Bio Angels, this discussion will feature an esteemed lineup of investor panelists, including Laura Rodriguez of Invivo Partners, Carla Benichou of RV Invest GmbH, and Artemy Shumsky of LongeVC. Their collective expertise will offer a comprehensive look at how investment and collaboration are shaping the future of biotech innovation.

Jim-McGough
Jim McGough
Managing Partner
Mid Atlantic Bio Angels
(Moderator)		 Carla-Benichou
Carla Benichou
Senior Investment Analyst
RV Invest GmbH
Laura-Rodriguez
Laura Rodriguez
Partner
Invivo Partners		 Artemy-Shumskiy
Artemy Shumskiy
Senior Associate
LongeVC

Investment and strategic partnering remain essential in advancing therapeutics that address high unmet medical needs. Whether you are a biotech entrepreneur seeking funding or an investor looking to stay ahead of industry trends, this panel promises valuable insights into the dynamic world of biotech investment.

Join us at RESI Europe to gain firsthand knowledge from top investors and forge meaningful connections that could help propel the next wave of groundbreaking therapies to market.

Leave a comment